Employers search
About Us
Telix is a global biopharmaceutical company specializing in the development and commercialization of radiopharmaceuticals to address unmet medical needs in cancer care and rare diseases.
Headquartered in Melbourne, Australia, Telix operates internationally and focuses on advancing innovative treatments to improve patient outcomes.
The company is publicly listed on the Australian Securities Exchange (ASX) and Nasdaq under the ticker symbol TLX.
